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The low success rate of somatic nuclear transfer (NT)
is hypothesized to be mainly due to functional
defects in the trophoblast cell lineage rather than
the inner cell mass (ICM); this hypothesis, however,
remains to be tested directly. Here we separated
the ICMs from cloned blastocysts and aggregated
the cloned ICM with two fertilization-derived (FD)
tetraploid (4N) embryos. We found that the full-term
development of cloned ICMs was dramatically
improved after the trophoblast cells in the cloned
blastocysts were replaced by cells from tetraploid
embryos, thus providing direct evidence that defects
in trophoblast cell lineage underlie the low success
rate of somatic NT.
The tetraploid (4N) embryo complementation strategy has been
widely used to rescue the placental dysfunction that otherwise
would result in fetal death (Okada et al., 2007). Tetraploid cells
can give rise to extraembryonic tissues, but rarely contribute to
the embryo itself (Li et al., 2005; Nagy et al., 1990). We thus
reasoned that if the low efficiency of cloning is mainly due to
placental defects, one might be able to improve the birth rate
of cloned embryos by aggregating the cloned embryos with
wild-type tetraploid embryos. In our experiments, MII oocytes
were obtained from superovulated wild-type B6D2F1 mice and
cumulus cells (CCs) around the oocytes from wild-type or trans-
genic B6D2F1 mice expressing the enhanced green fluores-
cence protein (GFP) controlled by the chicken b-actin promoter
(GFP mice) were used as donors for NT. In the first set of exper-
iments, cloned blastocysts from wild-type CCs were transferred
into the uteruses of pseudopregnant ICR females directly
(termed one-step NT). From 514 transferred blastocysts, we
obtained 14 cloned mice (2.7%, Table 1), an efficiency similar
to that reported previously (Li et al., 2007).
We next aggregated one 8-cell stage NT embryo with one to
three 4-cell stage FD tetraploid embryos. To generate aggre-
gated embryos, the zona pellucida was removed using acid
Tyrode solution. One to three zona-free tetraploid embryoswere placed in small holes of a plastic dish, and one zona-free
cloned embryo was added to each hole. The aggregated
embryos (termed NT2N/FD4N embryos) were cultured individu-
ally in vitro to blastocyst stage and transferred into the uteruses
of recipient females. We found that tetraploid embryos with
B6D2F2 background did not improve the birth rate of cloned
embryos (from GFP CCs) after aggregation and the highest
efficiency was obtained when two tetraploid embryos were
used (Table 1). When one or three tetraploid embryos of ICR
mice were aggregated with one cloned embryo from wild-type
CCs, the birth rates were not different from those of one-step
NT (3.3% or 3.8% versus 2.7%, Table 1). However, the birth
rate was 2.6-fold higher when two FD tetraploid embryos from
ICR mice were used for aggregation compared with that of
one-step NT (7.1% versus 2.7%, p < 0.05, Table 1). It has
been reported that tetraploid embryonic developmental poten-
tial is influenced by genetic background (Eakin et al., 2005) and
the number of tetraploid embryos could affect the development
of tetraploid blastocysts complemented with ESCs (Ohta et al.,
2008). Thus, we used two tetraploid embryos from the B6D2F2
or ICR mice for subsequent aggregation experiments. In this
set of experiments, we generated a total of 30 mice, which are
referred to as clonal mice, to reflect the possibility of tetraploid
cell content in the mice (Li et al., 2005). Our data suggest that
developmental potency of cloned embryos can be significantly
improved when the cloned placentae are integrated with func-
tional FD tetraploid cells from outbred mice (Table 1). Neverthe-
less, in these aggregated embryos, trophoblast cells of the 2N
cloned embryos could still contribute to the placentae, which
may negatively impact the embryonic development of the cloned
ICMs, resulting in some embryos that fail to develop to term. In
support of this idea, we observed more dead fetuses with
placentae in this set of experiments when the recipient females
were subjected to cesarean section on Day 19.5 of gestation
than those in one-step NT experiments (Table 1).
We thus asked whether an even higher efficiency of
clonal mice derivation can be achieved if trophoblast cells of
the 2N cloned embryos are completely replaced by the func-
tional FD tetraploid cells. To this end, we selectively removed
the outer trophectoderm (TE) cells and isolated the ICMs from
the cloned blastocysts by immunosurgery. We aggregated
a single cloned ICM with two 4-cell stage tetraploid embryosCell Stem Cell 8, 371–375, April 8, 2011 ª2011 Elsevier Inc. 371
Table 1. In Vivo Development of Aggregated Embryos Generated by Different Strategies
Embryo
Type
Strain of 2N
Embryos
or ICMs
Strain of 4N
Embryos
No. of Embryos
Aggregated
(2N:4N)
No. of
Blastocysts
Transferred
No. of Transferred
Females (Pregnant
Females)
No. of Dead
Fetuses with
Placentae
(% of Transferred
Blastocysts)
No. of Liveborn
Mice (% of
Transferred
Blastocysts)
No of Surviving
Mice (% of
Liveborn Mice)
Weight of
Pups
(Mean ± SD)
Placental
Weight
(Mean ± SD)
NT only B6D2F1 / / 514 39 (13) 5 (1) 14 (2.7)A 10 (71.4) 1.5 ± 0.23 0.26 ± 0.07
NT2N/FD4N B6D2F1-GFP B6D2F2 1:1 130 11 (11) 0 1 (0.8)b * 1.56 0.18
NT2N/FD4N B6D2F1-GFP B6D2F2 1:2 150 14 (12) 1 (0.7) 3 (2.0)b * 1.45 ± 0.17 0.17 ± 0.04
NT2N/FD4N B6D2F1-GFP B6D2F2 1:3 44 6 (5) 0 0b / / /
NT2N/FD4N B6D2F1 ICR 1:1 153 11 (8) 3 (2) 5 (3.3)c 3 (60) 1.38 ± 0.41 0.16 ± 0.03
NT2N/FD4N B6D2F1 ICR 1:2 197 17 (15) 5 (2.5) 14 (7.1)a,c 10 (71.4) 1.45 ± 0.34 0.18 ± 0.07
NT2N/FD4N B6D2F1 ICR 1:3 183 14 (11) 16 (8.7) 7 (3.8)c 5 (71.4) 1.52 ± 0.22 0.17 ± 0.05
NTICM/FD4N B6D2F1-GFP B6D2F2 1:2 62 5 (4) 1 (1.6) 9 (14.5)a,B * 1.4 ± 0.3 0.17 ± 0.05
NTICM/FD4N B6D2F1 ICR 1:2 236 23 (22) 1 (0.4) 37 (15.7)a,C 29 (78.4) 1.5 ± 0.24 0.15 ± 0.05
Subtotal / / / 1669 140 (101) 32 (1.9) 90 (5.4) / / /
FDICM/NT4N B6D2F1 B6D2F1 1:2 81 8 (8) 1 (1.2) 3 (3.7)D 2 (66.7) 1.38 ± 0.16 0.27 ± 0.07
FD2N/FD4N B6D2F1 ICR 1:1 51 5 (5) 0 16 (31) nd 1.36 ± 0.13 0.1 ± 0.03
FDICM/FD4N B6D2F1 ICR 1:2 54 3 (3) 0 18 (33)d 16 (88.9) 1.32 ± 0.22 0.12 ± 0.03
FD only B6D2F1 / / / / / 14 / 1.34 ± 0.1 0.09 ± 0.01
A versus a; B versus b; C versus c; D versus d: p < 0.05; nd, nondetermined.
* Euthanized for chimerism analysis.
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Figure 1. Clonal Mice Generated after Aggregating One Cloned ICM with Two FD Tetraploid Embryos
(A) Schema of clonal mice generated after aggregation of one cloned ICM with two FD tetraploid embryos (ZP, zona pellucida; BL, blastocyst).
(B) Cloned blastocysts exposed to guinea pig complement following incubation with rabbit anti-mouse serum. Only the outer trophectoderm cells are lysed.
(C) Isolated cloned ICMs.
(D) An aggregated blastocyst in a depression well.
(E) Aggregated embryos developed to blastocyst stage in vitro.
(F) Newborn clonal mice generated from aggregated embryos.
(G) Three-week-old mice derived from aggregated embryos.
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Rescue of Trophoblast Defects Improves Cloning(termed NTICM/FD4N embryos) (Figures 1A–1C). The aggre-
gated embryos were cultured individually in vitro to blastocyst
stage (Figures 1D and 1E). As expected, the birth rate
after uterine transfer of successfully aggregated embryos
between cloned ICM (from wild-type CCs) and ICR tetraploid
embryos improved another 2-fold compared to that of NT2N/
FD4N (1:2)-aggregated embryos (15.7% versus 7.1%, p <
0.05, Figures 1F and 1G, Table 1) and was 6-fold higher than
that of one-step NT (15.7% versus 2.7%, p < 0.001, Table 1).
Surprisingly, although tetraploid embryos from B6D2F2 mice
could not improve the development of cloned embryos after
aggregation, the birth rate was consistently increased when
cloned ICM (from GFP CCs) was aggregated with tetraploid
embryos of B6D2F2 mice (14.5%, Table 1). Our repetitive exper-
iments demonstrate that the success rate of NT can be dramat-
ically improved when trophoblast cells of cloned embryos are re-
placed by FD tetraploid cells. Thus, defects in trophoblast cell
lineage indeed constitute a main cause for cloning failure.
To test chimerism of embryonic and extraembryonic tissues
in NTICM/FD4N-reconstituted embryos, we performed experi-ments in which we aggregated one GFP-positive ICM isolated
from cloned blastocysts with two wild-type tetraploid embryos.
By whole-mount immunostaining, we found that, at blastocyst
stage, around 65% of ICM cells and less than 1% of trophecto-
derm cells were green-fluorescent (Figures S1A–S1D). On Day
12.5 of gestation, we observed that tetraploid cells colonized
sporadically throughout the embryos (5 of 5) and GFP-express-
ing fetal capillaries and chorionic plate were frequently present in
aggregated placentae (5 of 5) (Figures S1E–S1H). In five newborn
mice and placentae analyzed, only one mouse contained limited
tetraploid cells in the gut and kidney, while ICM-originated cells
contributed to fetal capillaries and chorionic plate in all placentae
(Figures S1I–S1L), same as the normal placental development
in mice (Watson and Cross, 2005). These data indicate that
tetraploid cells, as reported previously (Eakin and Behringer,
2003; Li et al., 2005; MacKay and West, 2005; Nagy et al.,
1990), could persist to midgestation and even to term during
the development of tetraploid-complemented embryos.
We also performed the reciprocal experiments in which we
separated ICMs from FD blastocysts and aggregated one FDCell Stem Cell 8, 371–375, April 8, 2011 ª2011 Elsevier Inc. 373
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Rescue of Trophoblast Defects Improves CloningICM with two cloned tetraploid embryos produced from wild-
type CCs (termed FDICM/NT4N embryos). After transferring 81
aggregated blastocysts into uterus, we generated one stillborn
and three live-born mice. Interestingly, the birth rate was similar
to that of one-step NT (3.7% versus 2.7%), and significantly
lower than that of a control experiment in which a single normal
FD ICM was aggregated with two normal FD tetraploid embryos
(termed FDICM/FD4N embryos) (3.7% versus 33%, p < 0.05,
Table 1). These results further support that defects in tropho-
blast cell lineage of the cloned embryo, but not the ICM itself,
account for the frequent developmental failure associated with
cloning.
In total, we generated 90 cloned or clonal mice in this study.
To demonstrate that these mice derived entirely from the
somatic donor cells, we analyzed coat color and GFP expres-
sion and performed simple sequence-length polymorphism
(SSLP) analysis. When wild-type donor cells were used for NT,
all cloned or clonal mice exhibited uniformly black coat color,
which was different from both the albino tetraploid embryos
and the albino recipient females (Figure S2A). When GFP-trans-
genic somatic cells were used as donors, all clonal mice were
strongly green-fluorescent, while the placentae, which were
mostly contributed from wild-type B6D2F2 tetraploid embryos,
were not (Figure S2B). To further confirm the cell origin of these
mice, we performed SSLP. The results showed that the cloned
or clonal mice had a polymorphic pattern similar to that from
donor cell strain (B6D2F1), but different from tetraploid host
and recipient strain (ICR) (Figure S2C). Taken together, these
data conclusively demonstrate that the mice were cloned from
somatic cells.
Most of the cloned or clonal mice were not oversized at birth
(Table 1). However, placentae derived from one-step NT
and FDICM/NT4N-aggregated embryos weighed approximately
3-fold more than FD placentae (Table 1). Histological analysis of
these enlarged placentae revealed expansion of spongiotropho-
blast layer (Figure S2D). We also observed normal-looking
histology with only a slight enlargement in most placentae (10/
14) derived from NTICM/FD4N (Figures S2E and S2F). Further-
more, we analyzed the transcript levels of seven imprinted and
four nonimprinted genes in placentae of cloned, NTICM/FD4N,
and FD embryos by real-time quantitative RT-PCR. We found
that cloned placentae exhibited a significant reduction inmRNAs
for five imprinted and four nonimprinted genes compared with
FD placentae. Moreover, transcript levels for seven of these
nine genes showed recovery in placentae from NTICM/FD4N
(Figure S2G). To determine whether similar changes happened
in the organs of newborn mice from NTICM/FD4N, we examined
the expression levels of imprinted and organ-specific genes in
the kidney, heart, and liver of cloned and clonal mice. Improper
gene expression was observed in both cloned and clonal mice,
especially in kidney and heart (Figures S2H–S2J), indicating
that embryonic development of cloned or clonal mice may be
rather tolerant to epigenetic abnormalities (Humpherys et al.,
2001). Moreover, in contrast to placentae, normal gene expres-
sion was not generally restored in mice of NTICM/FD4N. These
results suggest that the hyperplastic phenotype and abnormal
gene expression of cloned placentae could be ameliorated by
aggregating cloned ICM with tetraploid embryos, resulting in
higher-term developmental rate of cloned embryos.374 Cell Stem Cell 8, 371–375, April 8, 2011 ª2011 Elsevier Inc.Recently, two independent research groups (Oda et al., 2009;
Rielland et al., 2009) investigated the etiology of the placental
defects in cloned mice and derived trophoblast stem (TS) cells
from cloned embryos. In both reports, nuclear transfer TS
(NTTS) cells could easily be generated and were shown to
possess a normal phenotype in vitro and in vivo. Similarly,
nuclear transfer embryonic stem (NTES) cells can be efficiently
derived from cloned ICMs and exhibit equivalent properties to
normal ESCs (Brambrink et al., 2006; Wakayama et al., 2006).
Thus, it is puzzling that both NTTS and NTES cells are indistin-
guishable from those derived from normal embryos despite the
fact that the cloned embryos have many defects (Soares and
Asanoma, 2009). To investigate the effect of extraembryonic
tissues on clone-associated developmental failure, the tetraploid
embryos have been used to complement the placental defi-
ciency in cloned embryos (Jouneau et al., 2006; Miki et al.,
2009). However, in these aggregation experiments, cloned
trophoblast cells still contributed to the resulting placentae,
thus providing the indirect experiment evidences, which might
be the exact opposite (Jouneau et al., 2006; Miki et al., 2009).
To completely test the ‘‘trophoblast lineage defects’’ hypothesis
(Yang et al., 2007), the best experiment is to replace the cloned
trophoblast with wild-type tetraploid cells. Using this strategy,
Kato et al. (1999) failed to rescue the development of cloned
embryos from primordial germ cells, probably due to a lack of
gametic imprints in donor cells. In another report, after injection
of cloned ICM into one tetraploid blastocyst, cloning success
was not improved, reflecting that the number of tetraploid
embryos is a critical factor in tetraploid complementation exper-
iments (Amano et al., 2002). Here, using a modified aggregation
system, we found that cloning efficiency can be significantly
improved when defects in cloned placentae were partially
rescued by combination with functional tetraploid placentae
(NT2N/FD4N aggregations), and can be further improved if the
cloned trophoblast cell lineage were replaced completely by
tetraploid cells (NTICM/FD4N aggregations). Furthermore, in
reciprocal experiments, when the trophoblast cell lineage of
normal FD embryos were replaced by that of NT origin
(FDICM/NT4N aggregations), embryonic development was
dramatically impaired, resulting in a birth rate that is comparable
to that of one-step NT. In summary, our study provides the most
direct evidence to date that cloned trophoblast cell lineage, but
not the ICM, constitutes the main cause for the poor develop-
ment of cloned embryos in vivo.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.stem.2011.02.007.
ACKNOWLEDGMENTS
We thank W. Tang, D. Liang, Y. Tao and Y. Li for technical assistance. We
thank Drs. N. Jing and X. Ding for critical and useful comments on the manu-
script. The study was supported by grants from the Chinese Academy of
Sciences (KSCX2-YW-R-110, KSCX2-YW-R-229, XDA01010403), theMinistry
of Science and Technology (2007CB947101, 2009CB941101), the National
Natural Science Foundation of China (30871430), and the Shanghai Municipal
Commission for Science and Technology (07DZ22919, 08DJ1400502,
09PJ1410900).
Cell Stem Cell
Rescue of Trophoblast Defects Improves CloningReceived: August 5, 2010
Revised: January 9, 2011
Accepted: February 10, 2011
Published: April 7, 2011
REFERENCES
Amano, T., Kato, Y., and Tsunoda, Y. (2002). The developmental potential of
the inner cell mass of blastocysts that were derived frommouse ES cells using
nuclear transfer technology. Cell Tissue Res. 307, 367–370.
Brambrink, T., Hochedlinger, K., Bell, G., and Jaenisch, R. (2006). ES cells
derived from cloned and fertilized blastocysts are transcriptionally and func-
tionally indistinguishable. Proc. Natl. Acad. Sci. USA 103, 933–938.
Eakin, G.S., and Behringer, R.R. (2003). Tetraploid development in the mouse.
Dev. Dyn. 228, 751–766.
Eakin, G.S., Hadjantonakis, A.K., Papaioannou, V.E., and Behringer, R.R.
(2005). Developmental potential and behavior of tetraploid cells in the mouse
embryo. Dev. Biol. 288, 150–159.
Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger, K., Rideout, W.M., 3rd,
Biniszkiewicz, D., Yanagimachi, R., and Jaenisch, R. (2001). Epigenetic insta-
bility in ES cells and cloned mice. Science 293, 95–97.
Jouneau, A., Zhou, Q., Camus, A., Brochard, V., Maulny, L., Collignon, J., and
Renard, J. (2006). Developmental abnormalities of NT mouse embryos appear
early after implantation. Development 133, 1597–1607.
Kato, Y., Rideout, W.M., 3rd, Hilton, K., Barton, S.C., Tsunoda, Y., and Surani,
M.A. (1999). Developmental potential of mouse primordial germ cells.
Development 126, 1823–1832.
Li, J., Ishii, T., Wen, D., and Mombaerts, P. (2005). Non-equivalence of cloned
and clonal mice. Curr. Biol. 15, R756–R757.
Li, J., Greco, V., Guasch, G., Fuchs, E., andMombaerts, P. (2007). Mice cloned
from skin cells. Proc. Natl. Acad. Sci. USA 104, 2738–2743.
MacKay, G.E., and West, J.D. (2005). Fate of tetraploid cells in 4n42n
chimeric mouse blastocysts. Mech. Dev. 122, 1266–1281.Miki, H., Wakisaka, N., Inoue, K., Ogonuki, N., Mori, M., Kim, J.M., Ohta, A.,
and Ogura, A. (2009). Embryonic rather than extraembryonic tissues have
more impact on the development of placental hyperplasia in cloned mice.
Placenta 30, 543–546.
Nagy, A., Go´cza, E., Diaz, E.M., Prideaux, V.R., Iva´nyi, E., Markkula, M., and
Rossant, J. (1990). Embryonic stem cells alone are able to support fetal
development in the mouse. Development 110, 815–821.
Oda, M., Tanaka, S., Yamazaki, Y., Ohta, H., Iwatani, M., Suzuki, M., Ohgane,
J., Hattori, N., Yanagimachi, R., Wakayama, T., and Shiota, K. (2009).
Establishment of trophoblast stem cell lines from somatic cell nuclear-trans-
ferred embryos. Proc. Natl. Acad. Sci. USA 106, 16293–16297.
Ohta, H., Sakaide, Y., Yamagata, K., and Wakayama, T. (2008). Increasing the
cell number of host tetraploid embryos can improve the production of mice
derived from embryonic stem cells. Biol. Reprod. 79, 486–492.
Okada, Y., Ueshin, Y., Isotani, A., Saito-Fujita, T., Nakashima, H., Kimura, K.,
Mizoguchi, A., Oh-Hora, M., Mori, Y., Ogata, M., et al. (2007).
Complementation of placental defects and embryonic lethality by tropho-
blast-specific lentiviral gene transfer. Nat. Biotechnol. 25, 233–237.
Rielland, M., Brochard, V., Lacroix,M.C., Renard, J.P., and Jouneau, A. (2009).
Early alteration of the self-renewal/differentiation threshold in trophoblast stem
cells derived from mouse embryos after nuclear transfer. Dev. Biol. 334,
325–334.
Soares, M.J., and Asanoma, K. (2009). Trophoblast stem cells derived from
nuclear transfer embryos: Phenotypically unique, bad neighbors, or poor
communicators? Proc. Natl. Acad. Sci. USA 106, 16014–16015.
Wakayama, S., Jakt, M.L., Suzuki, M., Araki, R., Hikichi, T., Kishigami, S., Ohta,
H., Van Thuan, N., Mizutani, E., Sakaide, Y., et al. (2006). Equivalency of
nuclear transfer-derived embryonic stem cells to those derived from fertilized
mouse blastocysts. Stem Cells 24, 2023–2033.
Watson, E.D., and Cross, J.C. (2005). Development of structures and transport
functions in the mouse placenta. Physiology (Bethesda) 20, 180–193.
Yang, X., Smith, S.L., Tian, X.C., Lewin, H.A., Renard, J.P., and Wakayama, T.
(2007). Nuclear reprogramming of cloned embryos and its implications for
therapeutic cloning. Nat. Genet. 39, 295–302.Cell Stem Cell 8, 371–375, April 8, 2011 ª2011 Elsevier Inc. 375
